Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.

Revenue
+1.42%
EPS
+17.9%
Free cash flow
+29.0%
Total debt
−3.65%

Quarter to September 2026, against a year earlier

425.62 6.38 −1.48%
Market cap
$93.3B
P/E
18.2×
Fwd P/E
19.0×
Dividend yield
1.61%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

13.96 12.45 17.19 16.58
P/S ratio
0.39 0.32 0.42 0.42
P/FCF ratio
24.74 9.98 13.34 12.93
P/Operating CF
934.80 14.85 43.87 66.47
P/B ratio
1.78 1.46 1.86 1.88
EV/Sales
0.37 0.29 0.39 0.38
EV/EBITDA
7.69 6.38 8.79 8.40
EV/FCF
23.41 9.05 12.32 11.84
Current Ratio
1.54 1.48 1.52 1.47
Net Debt/EBITDA
(4.27) (1.98) (2.43) (2.82)
Debt/Equity
0.72 0.71 0.69 0.69
Earnings Yield
7.17% 8.03% 5.82% 6.03%
Free Cash Flow Yield
4.04% 10.02% 7.49% 7.73%
Free Cash Flow per Share
(0.93) 18.64 7.49 4.62
Book value per Share
196.54 200.37 207.47 206.81
Free Cash Flow
(209.00) 4,097.00 1,626.00 1,000.00
EV/EBIT
9.16 7.65 10.61 10.02
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026